- Home
- Companies
- Alfa Cytology
- Articles
Alfa Cytology articles
Alfa Cytology has announced tumor models customization service for pancreatic cancer research.
Alfa Cytology, a biotech company specializing in cancer research, has recently unveiled the service on pancreatic cancer tumor model customization to dig into the generation and development of pancreatic cancer and correspondingly provides customized plans for study.
Pancreatic cancer is one kind
Breast cancer is a type of cancer that begins in the cells of the breast. It can occur in both men and women but is more common in women. Breast cancer can develop in different parts of the breast, including the tubes that carry milk to the nipple or the lobules that produce milk. The exact cause of breast cancer is not completely understood, but factors such as genetics, hormone situations, and lifestyle choices can increase the threat of developing the disease. Common sym
Alfa Cytology has announced pancreatic cancer vaccine development services to improve the efficacy and safety of related vaccines.
Alfa Cytology, a biotech company composed of scientists, bioinformatics, and oncologists, has recently announced its pancreatic cancer vaccine development services to provide further strategies for cancer therapy research.
Compared to other solid tumors, pancreatic cancer (PC) lacks effective
Cancer is a daunting diagnosis; however, the rapid advancements in oncology are continuously perfecting patient outcomes and quality of life. Among the groundbreaking developments, cancer vaccines are a promising frontier1. These vaccines are transforming how we approach cancer treatment, leveraging the body's immune system to fight malignancies more effectively. To grasp how cancer vaccines work, it is pivotal to understand two fundamental components of the immune system: antig
Brain tumors can be broadly categorized into primary and secondary (or metastatic) tumors. Primary tumors originate in the brain1, while secondary tumors spread from other body parts. Treatment options traditionally include surgery, radiation therapy, and chemotherapy. However, these approaches can be invasive and have severe side effects.
The battle against brain tumors is being revolutionized by biotechnology, leveraging cutting-edge innovations to de